norgestimate has been researched along with gestodene in 28 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (10.71) | 18.7374 |
| 1990's | 22 (78.57) | 18.2507 |
| 2000's | 3 (10.71) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Corson, SL; Kafrissen, ME | 1 |
| London, RS | 1 |
| Rebar, RW; Zeserson, K | 1 |
| Babor, P; Feichtinger, W; Herczeg, KM; Heyda, M; Hoffmann, R; Plöckinger, B; Steinhauser, B | 1 |
| Hahn, DW; McGuire, JL; Phillips, A | 1 |
| Roy, S; Stanczyk, FZ | 1 |
| Chez, RA | 1 |
| Rabe, T; Runnebaum, B | 1 |
| Göretzlehner, G; Köhler, G | 1 |
| Jung-Hoffmann, C; Kuhl, H; Wiegratz, I | 1 |
| Sobel, NB | 1 |
| Affinito, P; Di Carlo, C; Farace, MJ; Monterubbianesi, M; Nappi, C; Petrillo, G; Primizia, M; Regine, V | 1 |
| DeCherney, A; Speroff, L | 1 |
| Creatsas, G; Serfaty, D; Verougstraete, A; Wildemeersch, D | 1 |
| Borm, GF; Coenen, CM; Rolland, R; Thomas, CM | 1 |
| Teichmann, A | 1 |
| Amiral, J; Guize, L; Plu-Bureau, G; Scarabin, PY | 1 |
| Bruppacher, R; Heinemann, LA; Lewis, MA; MacRae, KD; Spitzer, WO | 1 |
| Handler, S; Huber, J; Kapiotis, S; Loner, U; Quehenberger, P; Schneider, B; Speiser, W | 1 |
| Bloemenkamp, KW; Helmerhorst, FM; Rosendaal, FR; Vandenbroucke, JP | 1 |
| Hamulyak, K; Heijnen, P; Hemker, HC; Nicolaes, GA; Rosing, J; Tans, G; Thomassen, MC; van der Ploeg, PM; van Oerle, R | 1 |
| Cao, S; Wang, Z | 1 |
| Stanczyk, FZ | 1 |
| Gross, W; Jung-Hoffmann, C; Kuhl, H; Wiegratz, I | 1 |
| Cusson, J; Heinemann, L; Lewis, M; Rainville, B; Spitzer, WO; Suissa, S | 1 |
| Milsom, I; Odlind, V; Persson, I; Victor, A | 1 |
| del Marmol, V; Gertsen, K; Teichmann, A | 1 |
11 review(s) available for norgestimate and gestodene
| Article | Year |
|---|---|
Comparative review of third-generation progestins.
Topics: Contraceptives, Oral; Desogestrel; Female; Humans; Norgestrel; Norpregnenes | 1992 |
The new era in oral contraception: pills containing gestodene, norgestimate, and desogestrel.
Topics: Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Desogestrel; Dose-Response Relationship, Drug; Female; Humans; Norgestrel; Norpregnenes; Pregnancy; Progesterone Congeners | 1992 |
Characteristics of the new progestogens in combination oral contraceptives.
Topics: Blood Coagulation; Carbohydrate Metabolism; Contraceptives, Oral, Combined; Desogestrel; Humans; Lipid Metabolism; Norgestrel; Norpregnenes; Progesterone Congeners | 1991 |
Metabolism of levonorgestrel, norethindrone, and structurally related contraceptive steroids.
Topics: Animals; Contraceptives, Oral, Combined; Desogestrel; Female; Humans; Levonorgestrel; Norethindrone; Norgestrel; Norpregnenes | 1990 |
Clinical aspects of three new progestogens: desogestrel, gestodene, and norgestimate.
Topics: Carbohydrate Metabolism; Desogestrel; Drug Evaluation; Female; Humans; Lipid Metabolism; Menstrual Cycle; Norgestrel; Norpregnenes; Pregnancy; Progesterone Congeners; Proteins | 1989 |
[New progestational hormones].
Topics: Contraceptives, Oral, Hormonal; Desogestrel; Female; Humans; Nandrolone; Norgestrel; Norpregnenes; Progesterone Congeners | 1988 |
Progestins in preventive hormone therapy. Including pharmacology of the new progestins, desogestrel, norgestimate, and gestodene: are there advantages?
Topics: Breast Neoplasms; Cardiovascular Diseases; Desogestrel; Endometrium; Estrogen Replacement Therapy; Female; Humans; Norgestrel; Norpregnenes; Osteoporosis, Postmenopausal; Progesterone Congeners; Risk Factors; Structure-Activity Relationship | 1994 |
Evaluation of a new generation of oral contraceptives. The Advisory Board for the New Progestins.
Topics: Androgens; Blood Coagulation; Blood Glucose; Contraceptives, Oral; Desogestrel; Female; Humans; Insulin; Lipid Metabolism; Norgestrel; Norpregnenes; Progesterone Congeners | 1993 |
[Advances in the research on new generation of oral contraceptive agents].
Topics: Contraceptives, Oral, Synthetic; Humans; Norgestrel; Norpregnenes | 1996 |
Pharmacokinetics of the new progestogens and influence of gestodene and desogestrel on ethinylestradiol metabolism.
Topics: Desogestrel; Ethinyl Estradiol; Female; Humans; Kinetics; Norgestrel; Norpregnenes; Progesterone Congeners | 1997 |
The role of combined oral contraceptives in the management of acne and seborrhea.
Topics: Acne Vulgaris; Contraceptives, Oral; Contraceptives, Oral, Combined; Dermatitis, Seborrheic; Desogestrel; Ethinyl Estradiol; Female; Humans; Norgestrel; Norpregnenes; Safety; Treatment Outcome | 2004 |
8 trial(s) available for norgestimate and gestodene
| Article | Year |
|---|---|
[Side effects of oral contraceptives in the first treatment cycle].
Topics: Adult; Contraceptives, Oral, Combined; Desogestrel; Dose-Response Relationship, Drug; Ethinyl Estradiol; Female; Fertilization in Vitro; Humans; Norgestrel; Norpregnenes; Pilot Projects; Prospective Studies; Retrospective Studies | 1991 |
Effect of two oral contraceptives containing ethinylestradiol and gestodene or norgestimate upon androgen parameters and serum binding proteins.
Topics: Adolescent; Adult; Androgens; Androstane-3,17-diol; Androstenedione; Carrier Proteins; Contraceptives, Oral; Contraceptives, Oral, Combined; Corticosterone; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Estradiol Congeners; Ethinyl Estradiol; Female; Humans; Hydrocortisone; Norgestrel; Norpregnenes; Radioimmunoassay; Sex Hormone-Binding Globulin; Testosterone | 1995 |
Efficacy, cycle control and side-effects of two monophasic combination oral contraceptives: gestodene/ethinylestradiol and norgestimate/ethinylestradiol.
Topics: Adult; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Italy; Menstrual Cycle; Norgestrel; Norpregnenes | 1993 |
Comparative evaluation of the androgenicity of four low-dose, fixed-combination oral contraceptives.
Topics: Adult; Androgens; Blood Pressure; Body Weight; Carrier Proteins; Contraceptives, Oral, Combined; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Desogestrel; Dihydrotestosterone; Dose-Response Relationship, Drug; Ethinyl Estradiol; Female; Humans; Hydroxyprogesterones; Norgestrel; Norpregnenes; Progesterone Congeners; Prospective Studies; Serum Albumin; Sex Hormone-Binding Globulin; Testosterone | 1995 |
Metabolic profile of six oral contraceptives containing norgestimate, gestodene, and desogestrel.
Topics: Adolescent; Adult; Cholesterol, HDL; Cholesterol, LDL; Contraceptives, Oral; Desogestrel; Dose-Response Relationship, Drug; Ethinyl Estradiol; Female; Humans; Lipid Metabolism; Lipids; Norgestrel; Norpregnenes; Progesterone Congeners | 1995 |
Increased levels of activated factor VII and decreased plasma protein S activity and circulating thrombomodulin during use of oral contraceptives.
Topics: Adult; Blood Coagulation; Blood Proteins; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Contraceptives, Oral, Synthetic; Ethinyl Estradiol; Factor VIIa; Female; Humans; Norgestrel; Norpregnenes; Prospective Studies; Protein S; Risk Factors; Thromboembolism; Thrombomodulin | 1996 |
Effect of two oral contraceptives containing ethinyl estradiol and gestodene or norgestimate on different lipid and lipoprotein parameters.
Topics: Adolescent; Adult; Apolipoproteins B; Cholesterol; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Drug Evaluation; Ethinyl Estradiol; Female; Humans; Lipids; Lipoproteins; Norgestrel; Norpregnenes; Phospholipids; Reference Values; Triglycerides | 1998 |
An open label, randomized study to evaluate the effects of seven monophasic oral contraceptive regimens on hemostatic variables. Outline of the protocol. Oral Contraceptive and Hemostasis Study Group.
Topics: Blood Coagulation; Contraceptives, Oral; Desogestrel; Ethinyl Estradiol; Female; Fibrin Fibrinogen Degradation Products; Fibrinolysis; Hemostasis; Humans; Levonorgestrel; Norgestrel; Norpregnenes; Peptide Fragments; Prothrombin; Thrombin; Venous Thrombosis | 1999 |
9 other study(ies) available for norgestimate and gestodene
| Article | Year |
|---|---|
Relative binding affinity of norgestimate and other progestins for human sex hormone-binding globulin.
Topics: Binding, Competitive; Desogestrel; Humans; Levonorgestrel; Norgestrel; Norpregnenes; Progesterone; Progestins; Sex Hormone-Binding Globulin; Testosterone | 1990 |
New progestogens in oral contraceptives.
Topics: Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Glucose; Glucose Tolerance Test; Humans; Insulin; Levonorgestrel; Lipids; Lipoproteins; Norgestrel; Norpregnenes; Progesterone Congeners | 1987 |
European Society of Contraception oral contraceptives survey update: birth control methods in "Europe of the 12".
Topics: Adult; Aging; Cardiovascular Diseases; Contraception; Contraceptives, Oral; Data Collection; Desogestrel; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Estradiol Congeners; Ethinyl Estradiol; Europe; Female; Humans; Levonorgestrel; Norgestrel; Norpregnenes; Progesterone; Progesterone Congeners; Risk Factors; Smoking; Surveys and Questionnaires | 1995 |
Safety of combined oral contraceptive pills.
Topics: Adult; Blood Coagulation Factors; Contraceptives, Oral, Combined; Cross-Sectional Studies; Desogestrel; Female; Fibrinolysis; Humans; Lipids; Middle Aged; Norgestrel; Norpregnenes; Progesterone Congeners; Thromboembolism | 1996 |
The increased risk of venous thromboembolism and the use of third generation progestagens: role of bias in observational research. The Transnational Research Group on Oral Contraceptives and the Health of Young Women.
Topics: Adolescent; Adult; Bias; Contraceptives, Oral, Synthetic; Desogestrel; Female; Humans; Levonorgestrel; Norgestrel; Norpregnenes; Odds Ratio; Progesterone Congeners; Risk Factors; Thromboembolism | 1996 |
Risk of oral contraceptives and recency of market introduction.
Topics: Adolescent; Adult; Contraceptives, Oral, Synthetic; Desogestrel; Female; Humans; Levonorgestrel; Norgestrel; Norpregnenes; Odds Ratio; Time Factors | 1997 |
Oral contraceptives and venous thrombosis: different sensitivities to activated protein C in women using second- and third-generation oral contraceptives.
Topics: Adolescent; Adult; Aged; Contraceptives, Oral, Combined; Desogestrel; Factor V; Female; Hemostasis; Heterozygote; Humans; Levonorgestrel; Male; Middle Aged; Norgestrel; Norpregnenes; Protein C; Thrombin; Thrombophlebitis | 1997 |
Recurrent use of newer oral contraceptives and the risk of venous thromboembolism.
Topics: Adult; Body Mass Index; Case-Control Studies; Contraceptives, Oral, Synthetic; Desogestrel; Estrogens; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Logistic Models; Norgestrel; Norpregnenes; Risk Factors; Venous Thrombosis | 2000 |
Can changes in sex hormone binding globulin predict the risk of venous thromboembolism with combined oral contraceptive pills?
Topics: Biomarkers; Contraceptives, Oral, Combined; Cyproterone Acetate; Desogestrel; Female; Humans; Levonorgestrel; Norgestrel; Norpregnenes; Predictive Value of Tests; Risk Factors; Sex Hormone-Binding Globulin; Venous Thrombosis | 2002 |